These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33103266)

  • 1. The influence of p16 immunohistochemistry on diagnosis and management recommendation of melanocytic neoplasms by dermatopathologists: A prospective study.
    Terrell JR; Rybak I; Lyu Y; Konia T; Fung MA; Qi L; Kiuru M
    J Cutan Pathol; 2021 Aug; 48(8):1094-1097. PubMed ID: 33103266
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of p16 immunohistochemical stain to help differentiate inflamed melanocytic nevi from metastatic melanoma in the setting of immunotherapy.
    Adelman M; Lyons AB; Seale L; Friedman BJ
    J Am Acad Dermatol; 2020 Apr; 82(4):e117-e119. PubMed ID: 31765681
    [No Abstract]   [Full Text] [Related]  

  • 3. The p16-Ki-67-HMB45 Immunohistochemistry Scoring System is Highly Concordant With the Fluorescent In Situ Hybridization Test to Differentiate Between Melanocytic Nevi and Melanomas.
    Uguen A; Uguen M; Guibourg B; Talagas M; Marcorelles P; De Braekeleer M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):361-367. PubMed ID: 27490764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 loves me, p16 loves me not.
    McCalmont TH
    J Cutan Pathol; 2012 Dec; 39(12):1060-1. PubMed ID: 23181443
    [No Abstract]   [Full Text] [Related]  

  • 5. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
    Garola R; Singh V
    Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Expression of p16 in Melanocytic Lesions: An Updated Review and Meta-analysis.
    Koh SS; Cassarino DS
    Arch Pathol Lab Med; 2018 Jul; 142(7):815-828. PubMed ID: 29939777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas: a clinical follow-up study.
    Koh SS; Lau SK; Roehmholdt BF; Cassarino DS
    J Clin Pathol; 2022 Jan; 75(1):68-70. PubMed ID: 33753560
    [No Abstract]   [Full Text] [Related]  

  • 8. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis.
    Guo Y; Long J; Lei S
    J Cell Physiol; 2019 May; 234(5):7356-7367. PubMed ID: 30370527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients.
    Ghiorzo P; Villaggio B; Sementa AR; Hansson J; Platz A; Nicoló G; Spina B; Canepa M; Palmer JM; Hayward NK; Bianchi-Scarrà G
    Hum Pathol; 2004 Jan; 35(1):25-33. PubMed ID: 14745721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferentially expressed antigen in melanoma and p16 expression in acral melanocytic neoplasms.
    McBride JD; McAfee JL; Piliang M; Bergfeld WF; Fernandez AP; Ronen S; Billings SD; Ko JS
    J Cutan Pathol; 2022 Mar; 49(3):220-230. PubMed ID: 34476825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 Range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma.
    Oaxaca G; Billings SD; Ko JS
    J Cutan Pathol; 2020 Sep; 47(9):815-823. PubMed ID: 32330325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Detection of p16 in Clinical Samples.
    Karpathiou G; Peoc'h M
    Methods Mol Biol; 2018; 1726():123-142. PubMed ID: 29468549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanoma.
    See SHC; Finkelman BS; Yeldandi AV
    Pathol Res Pract; 2020 Sep; 216(9):153105. PubMed ID: 32825968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67.
    Milman T; Zhang Q; Ang S; Elder D; Ida CM; Salomao DR; Lally SE; Shields JA; Hamershock RA; Sioufi K; Shields CL; Eagle RC
    Hum Pathol; 2020 Sep; 103():107-119. PubMed ID: 32707054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas.
    Koh SS; Roehmholdt BF; Cassarino DS
    J Cutan Pathol; 2018 Dec; 45(12):891-896. PubMed ID: 30178478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p16 in Merkel cell carcinoma.
    Talsma CE; Wang M; Andea AA; Fullen DR; Harms PW; Chan MP
    J Cutan Pathol; 2021 Mar; 48(3):455-457. PubMed ID: 32592172
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma.
    de Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; de Almeida OP
    Head Neck Pathol; 2012 Sep; 6(3):297-304. PubMed ID: 22311377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma.
    Castaneda CA; Castillo M; Torres-Cabala C; Bernabe LA; Casavilca S; Villegas V; Sanchez J; de la Cruz M; Dunstan J; Cotrina JM; Gomez HL; Chavez C; Landa-Baella MP; Tello K; Felix BF; Abugattas J
    Clin Transl Oncol; 2019 Sep; 21(9):1127-1134. PubMed ID: 30778854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma.
    Sargen MR; Cloutier JM; Sarin KY; Rieger KE; Chu P; Swetter SM; Novoa RA
    Pigment Cell Melanoma Res; 2019 May; 32(3):474-478. PubMed ID: 30672662
    [No Abstract]   [Full Text] [Related]  

  • 20. p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry.
    Sparrow LE; Eldon MJ; English DR; Heenan PJ
    Am J Dermatopathol; 1998 Jun; 20(3):255-61. PubMed ID: 9650698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.